These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17631081)

  • 21. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies.
    Upadhyay GA; Choudhry NK; Auricchio A; Ruskin J; Singh JP
    J Am Coll Cardiol; 2008 Oct; 52(15):1239-46. PubMed ID: 18926327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H; Behrens S; Eisermann C
    Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience.
    Cha YM; Rea RF; Wang M; Shen WK; Asirvatham SJ; Friedman PA; Munger TM; Espinosa RE; Hodge DO; Hayes DL; Redfield MM
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1015-9. PubMed ID: 17711439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of P-wave dispersion is associated with a lower incidence of atrial fibrillation after cardiac resynchronization therapy.
    Ding LG; Hua W; Chu JM; Qiao Q; Chen KP; Wang FZ; Zhang S
    Chin Med J (Engl); 2012 Mar; 125(6):990-4. PubMed ID: 22613519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
    Ypenburg C; Sieders A; Bleeker GB; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2007 Dec; 154(6):1160-5. PubMed ID: 18035090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy.
    Michelucci A; Ricciardi G; Sofi F; Gori AM; Pirolo F; Pieragnoli P; Giaccardi M; Colella A; Porciani MC; Di Biase L; Padeletti L; Abbate R; Gensini GF
    J Card Fail; 2007 Apr; 13(3):207-10. PubMed ID: 17448418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac resynchronization therapy and atrial fibrillation.
    Kamath GS; Steinberg JS
    Cardiol J; 2009; 16(1):4-10. PubMed ID: 19130410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Septal atrial pacing for the prevention of atrial fibrillation.
    Hakacova N; Velimirovic D; Margitfalvi P; Hatala R; Buckingham TA
    Europace; 2007 Dec; 9(12):1124-8. PubMed ID: 18024494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-site left ventricular cardiac resynchronization therapy.
    Padeletti L; Colella A; Michelucci A; Pieragnoli P; Ricciardi G; Porciani MC; Tronconi F; Hettrick DA; Valsecchi S
    Am J Cardiol; 2008 Dec; 102(12):1687-92. PubMed ID: 19064025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in mitral regurgitation in patients undergoing cardiac resynchronization treatment: assessment of predictors by two-dimensional radial strain echocardiography.
    Goland S; Rafique AM; Mirocha J; Siegel RJ; Naqvi TZ
    Echocardiography; 2009 Apr; 26(4):420-30. PubMed ID: 19382944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy.
    Riedlbauchová L; Brunken R; Jaber WA; Popová L; Patel D; Lánská V; Civello K; Cummings J; Burkhardt JD; Saliba W; Martin D; Schweikert R; Wilkoff BL; Grimm R; Natale A
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):50-7. PubMed ID: 18803571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.